Get the Stockscreener App
4.19
2.95%
0.12
After Hours:
4.18
-0.01
-0.24%
Precigen Inc stock is traded at $4.19, with a volume of 2.61M.
It is up +2.95% in the last 24 hours and up +9.69% over the past month.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
See More
Previous Close:
$4.07
Open:
$4.06
24h Volume:
2.61M
Relative Volume:
0.53
Market Cap:
$1.48B
Revenue:
$6.23M
Net Income/Loss:
$-95.90M
P/E Ratio:
-10.74
EPS:
-0.39
Net Cash Flow:
$-68.47M
1W Performance:
+5.28%
1M Performance:
+9.69%
6M Performance:
+179.33%
1Y Performance:
+433.62%
1-Day Range:
$4.059
$4.23
1-Week Range:
$3.90
$4.54
52-Week Range:
$0.6916
$5.225
Precigen Inc Stock (PGEN) Company Profile
Name
Precigen Inc
Sector
Industry
Phone
301-556-9900
Address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
4.19 | 1.44B | 6.23M | -95.90M | -68.47M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.99 | 116.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.71 | 82.52B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.69 | 52.67B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
849.95 | 52.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.42 | 37.70B | 447.02M | -1.18B | -906.14M | -6.1812 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-15-25 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-22-24 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Initiated | JP Morgan | Neutral |
| Nov-18-22 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-25-21 | Initiated | Stifel | Buy |
| Feb-22-21 | Initiated | Wells Fargo | Overweight |
| Feb-18-21 | Initiated | B. Riley Securities | Buy |
| May-08-20 | Initiated | H.C. Wainwright | Buy |
View All
Precigen Inc Stock (PGEN) Latest News
Precigen (NASDAQ:PGEN) Shares Gap Down Following Insider Selling - MarketBeat
Monday’s Insider Activity: Andreessen Horowitz Leads Major Buys By Investing.com - Investing.com UK
Precigen Insider Sold Shares Worth $7,942,150, According to a Recent SEC Filing - marketscreener.com
Insider Selling: Precigen (NASDAQ:PGEN) Director Sells 1,900,036 Shares of Stock - MarketBeat
Kirk sells Precigen shares worth $7.9 million - Investing.com
Profit Review: Will Precigen Inc. stock see insider buyingInsider Selling & Real-Time Buy Signal Alerts - Улправда
Is Precigen Inc. stock a buy before product launchesTrade Risk Assessment & Real-Time Stock Entry Alerts - Улправда
Is Precigen Inc. stock a buy on dips2025 Price Targets & Verified Swing Trading Watchlists - ulpravda.ru
Sentiment Watch: Is Precigen Inc. stock a buy before product launchesJuly 2025 Action & Long Hold Capital Preservation Tips - ulpravda.ru
Market Outlook: Is Precigen Inc. stock a buy on dipsWeekly Profit Report & Real-Time Volume Analysis - ulpravda.ru
Trade Alert: Independent Director Of Precigen Jeffrey Kindler Has Sold Stock - simplywall.st
Nasdaq Moves: Will Precigen Inc. stock recover faster than peersWeekly Investment Recap & Long Hold Capital Preservation Plans - ulpravda.ru
PRECIGEN, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that purchased - PR Newswire
Working capital per share of Precigen Inc – SWB:I5X - TradingView — Track All Markets
Precigen (PGEN) director reports sale of 235,467 shares of common stock on 12/12/2025 - Stock Titan
US High Growth Tech Stocks To Watch December 2025 - simplywall.st
Precigen Director Jeffrey B Kindler Sells 235,467 Shares - TradingView — Track All Markets
Spotlighting Bridgewater Bancshares And 2 Other Growth Stocks With Strong Insider Ownership - simplywall.st
Precigen Earnings Notes - Trefis
Precigen, Inc. (NASDAQ:PGEN) is definitely on the radar of institutional investors who own 31% of the company - Yahoo Finance
Dir Kindler Files To Sell 235,467 Of Precigen Inc [PGEN] - TradingView — Track All Markets
Precigen (NASDAQ:PGEN) Trading 5.3% HigherHere's What Happened - MarketBeat
Diametric Capital LP Buys New Holdings in Precigen, Inc. $PGEN - MarketBeat
Precigen Stock Up 280% in a Year — Is FDA Approval Behind This Big New Investor Bet? - sharewise.com
Patient Capital Management LLC Sells 1,103,560 Shares of Precigen, Inc. $PGEN - MarketBeat
Precigen (PGEN): Valuation in Focus After FDA Approval and Strengthened Cash Position - Sahm
Free cash flow per share of Precigen Inc – BX:I5X - TradingView
Can Precigen's (PGEN) Revenue Surge Offset Concerns About Its Expanding Losses? - simplywall.st
Precigen (NASDAQ:PGEN) Trading Down 4.9%Here's Why - MarketBeat
Precigen Is Still A Buy After The Papzimeos Rally (NASDAQ:PGEN) - Seeking Alpha
Precigen Insider Sold Shares Worth $12,291,748, According to a Recent SEC Filing - marketscreener.com
Precigen, Inc. Opens with a 5.13% Gain Amid Ongoing Challenges - Markets Mojo
Precigen, Inc. Soars 26.94% to Hit Intraday High of $5.00 - Markets Mojo
Precigen, Inc. Hits Day High with 25.65% Surge in Stock Price - Markets Mojo
Is Precigen (NASDAQ:PGEN) Weighed On By Its Debt Load? - 富途牛牛
Precigen (PGEN) director Kirk sells shares worth $12.3 million By Investing.com - Investing.com Australia
Precigen (PGEN) director Kirk sells shares worth $12.3 million - Investing.com
[Form 4] PRECIGEN, INC. Insider Trading Activity - Stock Titan
Precigen, Inc. Hits Day Low of $3.88 Amid Price Pressure - Markets Mojo
Precigen, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
Precigen Stock Opens Weak with 11.75% Gap Down Amid Market Concerns - Markets Mojo
Shareholder Kapital Joe LLC Files To Sell 942,832 Of Precigen Inc [PGEN] - TradingView
Is Precigen Inc. stock supported by strong cash flowsJuly 2025 Momentum & Reliable Intraday Trade Plans - newser.com
Precigen (NASDAQ:PGEN) Stock Price Down 9%Time to Sell? - MarketBeat
Can technical indicators confirm Precigen Inc.’s reversal2025 Risk Factors & Safe Capital Growth Trade Ideas - newser.com
How to integrate Precigen Inc. into portfolio analysis tools - newser.com
Earnings visualization tools for Precigen Inc.2025 Institutional Moves & Short-Term Trading Alerts - newser.com
Published on: 2025-11-19 18:31:23 - newser.com
How Precigen Inc. stock performs in interest rate cyclesJuly 2025 Market Mood & Safe Swing Trade Setups - newser.com
Will Precigen Inc. stock benefit from commodity prices2025 Investor Takeaways & Weekly Consistent Profit Watchlists - newser.com
Shareholder Kapital Joe LLC Files To Sell 1,086,153 Of Precigen Inc [PGEN] - TradingView
Precigen Inc Stock (PGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.36%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):